OPRR Requests for Assurances to Comply with 45 CFR 46

To safeguard the rights and welfare of all human research subjects regardless of location, applicable federal policy requires that each entity involving human subjects in research must enter into a binding commitment to minimum standards for protection of human subjects, before such research is begun. The document containing this binding commitment is called an Assurance. A Single Project Assurance or SPA is used for an institution and an Agreement for an Independent Investigator (AII) for an individual without institutional affiliation.

No federal research that involves human subjects may take place at any site prior to approval by OPRR of required Assurance documents. As Principal Investigator, it is your responsibility to ensure that each performance site obtains OPRR approval prior to its involvement of human subjects. Failure to comply with the requirement for prior approval may result in fiscal sanctions by the awarding unit.

OPRR identifies those sites that it considers engaged in the research and seeks the assistance of the PI in identifying others. Each engaged site is in need of an SPA or IIA for the project. Collaborating institutions that have OPRR-approved Multiple Project Assurances (MPAs) do not need to provide additional Assurance documents. However, OPRR strongly recommends that the PI obtain certification of prior IRB review from each MPA site.

The PI receives a written request from OPRR upon which to act. A copy is forwarded by the PI to each collaborating site without an applicable MPA, whether identified by OPRR or not. Each required site prepares its assurance to comply by submission of the following to the PI who then forwards it to OPRR for approval prior to involvement of any human subjects in research:

A.     Single Project Assurance (SPA) or Agreement for an Independent Investigator (AII)
B.     Institutional Review Board (IRB) membership list (avoid conflicts with research team)

C.     Informed consent document (English translation) -waived if the designated IRB is of an MPA institution  (MPA institutions can elect to perform IRB review for others upon request).

Should additional protocols be undertaken subsequent to OPRR approval of the SPA or AII for this project, OPRR must approve each such protocol for proposed use by the awardee and all other sites prior to involvement of subjects. Accordingly, for each protocol (unless reviewed and approved by an MPA IRB), you will be expected to provide OPRR the following: (1) a copy of each subsequently proposed protocol after IRB review, (2) an Optional Form 310 (use RTF equivalent of /humansubjects/assurance/as-fm310.htm), and 3) IRB-approved consent text. Distribution of IRB-approved consent language by the awardee to other sites for review and use should be subsequent to OPRR approval.

The following OPRR reference materials and preparation aids, amongst others, are available from the Policy and Assurances Page/polasur.htm ):

1.   45 CFR 46 (regulatory standards)
2.   The Belmont Report (research ethics)
3.   Sample SPA
(use download format from library)
4.   Preparation Aid

5.   Pitfalls to Avoid (SPA prep)

6.   Tips on Informed Consent (text prep)

Additional Page materials are available, as needed, under Guidance and Educational Materials. The IRB Guidebook covers numerous general topics. OPRR Reports and OPRR Guidance cover specific topics which may apply to your project. OPRR Guidance includes the following:

7.    Engagement (SPA or AII may be needed)
8.    Certificate of Confidentiality Contacts

9.    Use of Another's IRB (review efficiencies)
        Use of Another's IRB (local issues)
10.  Informed Consent from Non-English

11.  HIV Status (two separate documents)
        HIV Status (two separate documents)

12.  Repositories


Please note that the sample SPA and AII are periodically revised. Please do not use earlier versions that you may have in your possession. The current SPA sample may be used by an institution that has its own Institutional Review Board (IRB), as well as by an institution which uses the IRB of another institution. AIIs are expected to designate the IRB of another entity.

Basic policy on protection of human subjects is given at Title 45 CFR Part 46, Subpart A. Subparts B, C and D cover policy regarding human subjects in special categories. IRB composition is discussed on page 7 under Section 46.107. Performance sites that do not already possess an IRB may wish to approach a collaborating institution or other nearby institution with an MPA on file with OPRR (/humansubjects/assurance/cfed-a-c.htm) to explore reliance upon an existing IRB. The process of informed consent is discussed on page 9 under Section 46.116.

The SPA must be submitted on organizational letterhead, and must be signed by the IRB Chair and by institutional official(s) who is (are) empowered to enter into binding agreements on behalf of the institution(s). The signatory official should not be a voting member of the IRB. Original signatures and original documents are required by OPRR. No investigator who is involved in the project should appear as a voting IRB member without appropriate disqualification from participation in IRB events which would constitute a conflict of interest.

All blank spaces shown in the SPA sample must be filled in with appropriate information, such as date of IRB approval. All documents should be identified with the name of the Principal Investigator and the project/protocol number. Any deviations from the sample's language should be highlighted for quick identification. Assurances should be received by OPRR within 30 days of receipt of OPRR's request letter. The signatory official should not be a voting member of the IRB. OPRR Assurance Coordinators are available to provide guidance to applicants and awardees who reside in states and foreign countries for which they are responsible (/ab-staff.htm). This is especially important if a project is a multi-site clinical trial.



(05-17-00)



Policy | Assurances | OHRP Home Page

If you have questions about human subject research, click   ohrp@osophs.dhhs.gov
If you have questions/suggestions about this web page, click  Webmaster
Updated June 19, 2001